Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUCA1 | P04066 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LGALS8 | O00214 | 4/20 | 0.32 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.32 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.32 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13822005 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL154476 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL6534721 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL10045765 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL12205165 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL7948561 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL12921945 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL20844917 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL22472219 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL31384230 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 554 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122091405-A | Composite activated carbon and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-20230192748-A1 | Etoposide Glycosides, Methods Of Making, And Uses Thereof As An Anti-Cancer Drug | DOUBLERAINBOW BIOSCIENCES INC. | 2023-06-22 | — | — | US | claimed |
| US-20230193336-A1 | ENASIDENIB GLYCOSIDES AND METHODS OF TREATING DISEASES ASSOCIATED WITH ISOCITRATE DEHYDROGENASE (IDH) DYSFUNCTION | DOUBLERAINBOW BIOSCIENCES INC. | 2023-06-22 | — | — | US | claimed |
| EP-4196516-A1 | POLYMERISATION PROCESSES | The University Of Bath (GB) | 2023-06-21 | — | — | EP | claimed |
| US-20230124589-A1 | Ivacaftor Glycosides, Methods Of Making, And Uses Thereof In Treating Cystic Fibrosis | DOUBLERAINBOW BIOSCIENCES INC. | 2023-04-20 | — | — | US | claimed |
| EP-4121546-A1 | ETOPOSIDE GLYCOSIDES, METHODS OF MAKING, AND USES THEREOF AS AN ANTI-CANCER DRUG | Doublerainbow Biosciences Inc. (US) | 2023-01-25 | — | — | EP | claimed |
| CN-115279915-A | Etoposide glycoside, preparation method thereof and application thereof as anticancer drug | 德瑞生物医药股份有限公司 | 2022-11-01 | — | — | CN | claimed |
| WO-2022034321-A1 | POLYMERISATION PROCESSES | THE UNIVERSITY OF BATH (GB) | 2022-02-17 | — | — | WO | claimed |
| WO-2021188457-A1 | ETOPOSIDE GLYCOSIDES, METHODS OF MAKING, AND USES THEREOF AS AN ANTI-CANCER DRUG | DOUBLERAINBOW BIOSCIENCES INC. (US) | 2021-09-23 | — | — | WO | claimed |
| WO-2021188459-A1 | IVACAFTOR GLYCOSIDES, METHODS OF MAKING, AND USES THEREOF IN TREATING CYSTIC FIBROSIS | DOUBLERAINBOW BIOSCIENCES INC. (US) | 2021-09-23 | — | — | WO | claimed |
| JP-H08500012-A | — | — | 1996-01-09 | — | — | JP | claimed |
| EP-0654087-A1 | A FACILE ENZYMATIC SYNTHESIS OF GALACTOSYL-BETA-1,3 GLYCALS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1995-05-24 | — | — | EP | claimed |
| EP-0448412-B1 | A route to glycals in the allal and gulal series | UNIV YALE (US) | 1995-02-15 | — | — | EP | claimed |
| EP-0598051-A1 | ENZYMATIC METHOD FOR SYNTHESIS OF CARBOHYDRATES | BIOFLEXIN AB (SE) | 1994-05-25 | — | — | EP | claimed |
| WO-1994002624-A1 | A FACILE ENZYMATIC SYNTHESIS OF GALACTOSYL-BETA-1,3 GLYCALS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1994-02-03 | — | — | WO | claimed |
| US-5278301-A | Route to glycals in the allal and gulal series | YALE UNIVERSITY (US) | 1994-01-11 | — | — | US | claimed |
| WO-1993003168-A1 | ENZYMATIC METHOD FOR SYNTHESIS OF CARBOHYDRATES | NILSSON KURT (SE) | 1993-02-18 | — | — | WO | claimed |
| EP-0448412-A2 | A route to glycals in the allal and gulal series | YALE UNIVERSITY (US) | 1991-09-25 | — | — | EP | claimed |
| US-4935503-A | One step; using peroxydisulfate, ferrous, azide, and chloride salt | BIOMIRA, INC. (CA) | 1990-06-19 | — | — | US | claimed |
| EP-0340780-A2 | Azidochlorination and diazidization of glycals | BIOMIRA, INC. (CA) | 1989-11-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230124589-A1 | Ivacaftor Glycosides, Methods Of Making, And Uses Thereof In Treating Cystic Fibrosis | UGGT1, UGDH, GALE | FUCA1 7/4885L3MBTL1 1359/4885ALDH1A1 395/4885 |
| US-20230193336-A1 | ENASIDENIB GLYCOSIDES AND METHODS OF TREATING DISEASES ASSOCIATED WITH ISOCITRATE DEHYDROGENASE (IDH) DYSFUNCTION | UGDH, IDH1, G6PD | FUCA1 31/4885L3MBTL1 1574/4885ALDH1A1 292/4885 |
| US-20230192748-A1 | Etoposide Glycosides, Methods Of Making, And Uses Thereof As An Anti-Cancer Drug | GALE, UGGT1, DERA | FUCA1 8/4885L3MBTL1 1063/4885ALDH1A1 907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.